The oral LD50 of oxandrolone in mice and dogs is greater than 5,000 mg/kg.
A synthetic hormone with anabolic and androgenic properties.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Oxandrolone is combined with Cyclosporine. |
| Phenindione | Oxandrolone may increase the anticoagulant activities of Phenindione. |
| 4-hydroxycoumarin | Oxandrolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Oxandrolone may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Oxandrolone may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Oxandrolone may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Clorindione | Oxandrolone may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Oxandrolone may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Oxandrolone may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Oxandrolone may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | Oxandrolone may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Oxandrolone may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Oxandrolone may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Oxandrolone may increase the hypoglycemic activities of Insulin pork. |
| Sulfisoxazole | Oxandrolone may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | Oxandrolone may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | Oxandrolone may increase the hypoglycemic activities of Acarbose. |
| Metformin | Oxandrolone may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | Oxandrolone may increase the hypoglycemic activities of Sulfadiazine. |
| Miglitol | Oxandrolone may increase the hypoglycemic activities of Miglitol. |
| Pentamidine | Oxandrolone may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | Oxandrolone may increase the hypoglycemic activities of Mifepristone. |
| Repaglinide | Oxandrolone may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | Oxandrolone may increase the hypoglycemic activities of Phenformin. |
| Bromocriptine | Oxandrolone may increase the hypoglycemic activities of Bromocriptine. |
| Mitiglinide | Oxandrolone may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | Oxandrolone may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | Oxandrolone may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | Oxandrolone may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Oxandrolone may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Oxandrolone may increase the hypoglycemic activities of Pramlintide. |
| Insulin aspart | Oxandrolone may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Oxandrolone may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Oxandrolone may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Oxandrolone may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Oxandrolone may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Oxandrolone may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Oxandrolone may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Oxandrolone may increase the hypoglycemic activities of Voglibose. |
| NN344 | Oxandrolone may increase the hypoglycemic activities of NN344. |
| AMG-222 | Oxandrolone may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Oxandrolone may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | Oxandrolone may increase the hypoglycemic activities of Alogliptin. |
| Saxagliptin | Oxandrolone may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | Oxandrolone may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Oxandrolone may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | Oxandrolone may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | Oxandrolone may increase the hypoglycemic activities of Canagliflozin. |
| Benfluorex | Oxandrolone may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | Oxandrolone may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | Oxandrolone may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Oxandrolone may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | Oxandrolone may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Oxandrolone may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Oxandrolone may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Oxandrolone may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | Oxandrolone may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | Oxandrolone may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Oxandrolone may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Oxandrolone may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Oxandrolone may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Oxandrolone may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Oxandrolone may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Oxandrolone may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Oxandrolone may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | Oxandrolone may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | Oxandrolone may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Oxandrolone may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Oxandrolone may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Oxandrolone may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Oxandrolone may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Oxandrolone may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Oxandrolone may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Oxandrolone may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | Oxandrolone may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | Oxandrolone may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Guar gum | Oxandrolone may increase the hypoglycemic activities of Guar gum. |
| Semaglutide | Oxandrolone may increase the hypoglycemic activities of Semaglutide. |
| Taspoglutide | Oxandrolone may increase the hypoglycemic activities of Taspoglutide. |
| Englitazone | Oxandrolone may increase the hypoglycemic activities of Englitazone. |
| Tirzepatide | Oxandrolone may increase the hypoglycemic activities of Tirzepatide. |
| Gastric inhibitory polypeptide | Oxandrolone may increase the hypoglycemic activities of Gastric inhibitory polypeptide. |
| Pioglitazone | Oxandrolone may increase the hypoglycemic activities of Pioglitazone. |
| Flunisolide | The risk or severity of fluid retention can be increased when Flunisolide is combined with Oxandrolone. |
| Beclomethasone dipropionate | The risk or severity of fluid retention can be increased when Beclomethasone dipropionate is combined with Oxandrolone. |
| Betamethasone | The risk or severity of fluid retention can be increased when Betamethasone is combined with Oxandrolone. |
| Fluticasone propionate | The risk or severity of fluid retention can be increased when Fluticasone propionate is combined with Oxandrolone. |
| Triamcinolone | The risk or severity of fluid retention can be increased when Triamcinolone is combined with Oxandrolone. |
| Prednisone | The risk or severity of fluid retention can be increased when Prednisone is combined with Oxandrolone. |
| Fludrocortisone | The risk or severity of fluid retention can be increased when Fludrocortisone is combined with Oxandrolone. |
| Hydrocortisone | The risk or severity of fluid retention can be increased when Hydrocortisone is combined with Oxandrolone. |
| Prednisolone | The risk or severity of fluid retention can be increased when Prednisolone is combined with Oxandrolone. |
| Methylprednisolone | The risk or severity of fluid retention can be increased when Methylprednisolone is combined with Oxandrolone. |
| Trilostane | The risk or severity of fluid retention can be increased when Trilostane is combined with Oxandrolone. |
| Budesonide | The risk or severity of fluid retention can be increased when Budesonide is combined with Oxandrolone. |
| Dexamethasone | The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxandrolone. |
| Corticotropin | The risk or severity of fluid retention can be increased when Corticotropin is combined with Oxandrolone. |
| Cortisone acetate | The risk or severity of fluid retention can be increased when Cortisone acetate is combined with Oxandrolone. |
| Paramethasone | The risk or severity of fluid retention can be increased when Paramethasone is combined with Oxandrolone. |
| Ciclesonide | The risk or severity of fluid retention can be increased when Ciclesonide is combined with Oxandrolone. |